Home Ahead of print Instructions
About us Current issue Subscribe
Editorial board Archives Contact us
Search Submit article Login 
Print this page Email this page
REVIEW ARTICLE
Year : 2022  |  Volume : 19  |  Issue : 1  |  Page : 8-14

Thyroid Stimulating Hormone (TSH) estimation using point of care testing devices: Pitfalls and opportunities for improvement


1 Department of Medical Laboratory Science, School of Basic Medical Sciences, University of Benin; Molecular Biology Unit, Clina-Lancet Laboratories, Lagos, Nigeria
2 Department of Clinical Chemistry, Clina-Lancet Laboratories, Lagos, Nigeria
3 Department of Chemical Pathology and Immunology, Bayero University, Kano, Nigeria

Correspondence Address:
Mark Onyemaechi Ezegbogu
Department of Medical Laboratory Science, School of Basic Medical Sciences, University of Benin; Molecular Biology Unit, Clina-Lancet Laboratories, Lagos
Nigeria
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/njbcs.njbcs_47_21

Rights and Permissions

Since the development of the first Point-of-care Testing device (POCT) in 1962, POCTs have found their way into nearly every facet of laboratory diagnostics due to their rapid turn-around-times, testing convenience, ease of use, and relatively lower costs. This review provides an update on the progress in the development of POCTs for TSH assays while highlighting the challenges of these methods and suggesting ways of overcoming them. To achieve this, a literature search of the appropriate databases (Google Scholar, MEDLINE, Science Direct, and PubMed) was conducted using the keywords: POCT, TSH, hyperthyroidism, and hypothyroidism. Relevant articles were identified, duplicates eliminated, then critically analyzed, and discussed in terms of their relevance to the research questions. The different sensitivities of the POCTs reported in the scientific literature are traceable to the peculiarities of the detection technique adopted and the sensitivity of the immune complex recognition, i.e., labelled versus unlabeled immunoassay methods. The main factors limiting the wide acceptance of POCTs are concerns over their clinical usefulness, accuracy, and data (in)security. Routine assessment of the technical competence of POCT operators and regular quality checks of the performance of these devices are critical to maintaining the clinical usefulness of POCTs in TSH measurement. Finally, further research is required to understand the dynamic expectations of clinicians regarding POCT use in diagnosing thyroid dysfunction especially in low- and middle-income countries where data on this subject is lacking.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1731    
    Printed84    
    Emailed0    
    PDF Downloaded181    
    Comments [Add]    

Recommend this journal